William Ashton
CIK 1474553 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
47
Lifetime Open-Market Net
-$2.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDCXW | Director | — | $0.50 | — | $0 | 4 | 2026-06-04 |
| Societal CDMO, Inc. (SCTL) Delisted | Director | 0 | $1.10 | $0 | $10.1K | 4 | 2024-04-08 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 0 | $1.03 | $0 | -$114.9K | 9 | 2023-08-01 |
| Baudax Bio, Inc. (BXRX) Delisted | Director | 42,534 | $0.02 | $927 | $0 | 4 | 2022-06-17 |
| Societal CDMO, Inc. (REPH) Delisted | Director | 80,280 | $2.09 | $167.8K | $0 | 12 | 2021-05-17 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Director | 38,154 | — | — | $0 | 8 | 2017-10-10 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | -$2.26M | 6 | 2015-03-18 |
Recent Filings · Page 4 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-06 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | +9,866 | $5.8K | EDGAR |
| 2017-05-16 | Societal CDMO, Inc. (REPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-12 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | +9,870 | $5.8K | EDGAR |
| 2017-01-24 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | +2,946 | $5.8K | EDGAR |
| 2016-07-18 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-18 | Societal CDMO, Inc. (REPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-23 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-18 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Mixed | — | -$1.50M | EDGAR |
| 2014-12-19 | Societal CDMO, Inc. (REPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-13 | Societal CDMO, Inc. (REPH) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.